Results 111 to 120 of about 352,696 (330)

Pharmacogenomics in the UK National Health Service: Progress towards implementation

British Journal of Clinical Pharmacology, EarlyView.
Over the past decade there has been considerable and growing enthusiasm about the promise of using genomics to inform healthcare. In particular, using genetic data to inform prescribing practice has emerged as a compelling policy priority for health systems around the world, not least in the NHS.
John H. McDermott, Maria Tsakiroglou, William G. Newman, Munir Pirmohamed   +3 more
wiley   +1 more source

Exploring the utilisation and effectiveness of implementation science strategies by cystic fibrosis registries for healthcare improvement: a systematic review

European Respiratory Review
Background Cystic fibrosis (CF) registries capture important information in high-burden health domains to support improvement in health outcomes, although a number of unanswered questions persist, as follows.
Rob G. Stirling, Bhumika Sood, Macken J.L. Stirling, Tom Kotsimbos, Dominic T. Keating, Catherine E. Rang, James M. Trauer, Alan C. Young, Christiaan Yu, Julianna Bailey, Peter Wark, Angela Melder, Paul Dawkins   +12 more
doaj   +1 more source

Hyperpharmacotherapy in ageing cystic fibrosis patients: The first report of an atypical hip fracture

Respiratory Medicine Case Reports, 2015
Cystic fibrosis (CF) is a common autosomal recessive disorder in Caucasian populations with respiratory, gastrointestinal and endocrine manifestations.
W.A.K. Al-Azzani, L. Evans, L. Speight, M. Lea-Davies, M.D. Stone, D. Lau, R.I. Ketchell, J. Duckers   +7 more
doaj   +1 more source

Duodenal Fluid pH in Cystic Fibrosis [PDF]

, 1968
R.E. Knauff, J.A. Adams
openalex   +1 more source

Indicators of pulmonary exacerbation in cystic fibrosis: A Delphi survey of patients and health professionals [PDF]

, 2015
Background: There is uncertainty about the most important indicators of pulmonary exacerbations in CF. Methods: Two parallel Delphi surveys in 13 CF centres (UK and Ireland). Delphi 1: 31 adults with CF, ≥ one exacerbation over 12 months.
Abbott, Ahern, Barry Plant, Beretta, Bilton, Bowles, Bradley, Brenda O'Neill, Britto, Cystic Fibrosis Registry of Ireland, Dakin, de Boer, Elkins, Ellaffi, Elpern, European Medicines Agency, Evie McCrum-Gardner, Ferkol, Fiona McCourt, Food and Drug Administration, Gee, Goss, Guyatt, Hasson, Ian Logan, J. Stuart Elborn, Janice Abbott, Jones, Judy M. Bradley, Juniper, Keeney, Keeney, Kraynack, Liou, Paranjape, Quittner, Stephanie McKeown, Survey Monkey, UK Cystic Fibrosis Registry   +38 more
core   +1 more source

Cystic fibrosis

The Journal of the Royal College of Physicians of Edinburgh, 2013
There are now more adult than paediatric cystic fibrosis (CF) patients and their life expectancy continues to improve. This means that CF patients will be more commonly encountered in a variety of hospital settings including fertility services, gastrointestinal (GI) clinics, diabetes clinics, surgical wards, and acute admissions.
A E, Leitch, H C, Rodgers
openaire   +2 more sources

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

Cystic fibrosis and fertility. [PDF]

, 1968

openalex   +1 more source

Real‐world population pharmacokinetics of tezacaftor‐ivacaftor in children with cystic fibrosis: The SYM‐CF study

British Journal of Clinical Pharmacology, EarlyView.
Aims The clinical effectiveness of tezacaftor‐ivacaftor in children with cystic fibrosis (cwCF) varies; some patients respond while others do not or have adverse effects. The pharmacokinetics (PK) of tezacaftor‐ivacaftor are inadequately published, especially in children.
Steffie E. M. Vonk, Suzanne W. J. Terheggen‐Lagro, Eric G. Haarman, Hettie M. Janssens, Anke‐Hilse Maitland–van der Zee, E. Marleen Kemper, Ron A. A. Mathôt, on behalf of the Amsterdam Mucociliary Clearance Disease (AMCD) research group   +7 more
wiley   +1 more source

Eradication of Burkholderia cepacia Using Inhaled Aztreonam Lysine in Two Patients with Bronchiectasis

Case Reports in Pulmonology, 2014
There are not many articles about the chronic bronchial infection/colonization in patients with underlying lung disease other than cystic fibrosis (CF), especially with non-CF bronchiectasis (NCFBQ). The prevalence of B. cepacia complex is not well known
A. Iglesias, I. Artiles, J. J. Cabanillas, R. Álvarez-Sala, C. Prados   +4 more
doaj   +1 more source